| As emerging biotech firm Rainbow Biosciences, LLC, a subsidiary of Rainbow Coral Corp. (OTCBB:RBCC), closes in on a deal with a new clinical-stage company developing diagnostics and therapeutics for Parkinson's disease, the illness' commonalities with Alzheimer's disease could potentially lead to an even larger market for new therapies. A new therapeutic protein developed by RBCC's latest business target could prove key to reversing cell death caused by P...continued RBCC |
Wednesday, April 25, 2012
RBCC: Link Between Parkinson's and Alzheimer's Could Greatly Increase Market for New Therapies
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment